For many years, bilateral oopherectomy has been a routine part of hysterectomy. After a certain age, we reasoned that the role of the ovaries in helping women achieve hormonal balance was outweighed by the risks for ovarian cancer, thus offering women their best odds of long-term survival. Yet new evidence on the risks of routine bilateral oopherectomy challenges this conventional wisdom. Is it time we change our practice? Host Dr. Mark Nolan Hill examines the findings with Dr. William Parker, clinical professor of obstetrics and gynecology at the University of California, Los Angeles David Geffen School of Medicine, and a faculty member of the John Wayne Cancer Institute in Santa Monica, California. The lead author of a study published in Obstetrics and Gynecology, Dr. Parker also explores the mechanisms behind the potential risks investigated by his team, ranging from specific cancers to heart disease and all-cause mortality.
Rethinking Risk of Bilateral Oopherectomy With Hysterectomy

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
For many years, bilateral oopherectomy has been a routine part of hysterectomy. After a certain age, we reasoned that the role of the ovaries in helping women achieve hormonal balance was outweighed by the risks for ovarian cancer, thus offering women their best odds of long-term survival. Yet new evidence on the risks of routine bilateral oopherectomy challenges this conventional wisdom. Is it time we change our practice? Host Dr. Mark Nolan Hill examines the findings with Dr. William Parker, clinical professor of obstetrics and gynecology at the University of California, Los Angeles David Geffen School of Medicine, and a faculty member of the John Wayne Cancer Institute in Santa Monica, California. The lead author of a study published in Obstetrics and Gynecology, Dr. Parker also explores the mechanisms behind the potential risks investigated by his team, ranging from specific cancers to heart disease and all-cause mortality.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Bridging Distances in PAH: Bringing Best Practices to the People Through Telementoring
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
Partnering with Patients: Building Effective Communication and Support in HF Care
Clinical Conundrums in ARIA: Nuances of Microhemorrhages when Evaluating an MRI for ARIA
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?